Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Nicholas Harvey, WCO21: The Royal Osteoporosis Society Research Roadmap

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 30th 2021

touchIMMUNOLOGY joins Professor Nicholas Harvey (University of Southampton, UK) at WCO21 to discuss the aims and hopes of the Royal Osteoporosis Society’s Research Roadmap initiative.

Questions
1. What are the current unmet needs in osteoporosis and bone research? (00:27-01:26)
2. Please can you provide a short summary of the main aims of the Osteoporosis and Bone Research Academy? (01:26-02:30)
3. What is the Research Roadmap and how will it be used? (02:30-03:28)
4. Who is involved in this initiative?(03:28-05:37)
5. What impact do you hope the Research Roadmap will have on managing osteoporosis in the future? (05:37-06:41)

Disclosures: Nicholas Harvey reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare, Kyowa Kirin and Internis Pharma.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.

Filmed in coverage of the WCO21 Annual Meeting.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup